Ethical dimensions of nuchal translucency screening

Clinics in Perinatology

Volumn 30, Issue 1, 2003, Pages 95-102

  Chasen, Stephen T ^a   Skupski, Daniel W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

AMNIOCENTESIS; AMNION; ANEUPLOIDY; BENEFICENCE; CALCULATION; CHEMICAL ANALYSIS; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CLINICAL TRIAL; CROWN RUMP LENGTH; DECISION MAKING; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; DOWN SYNDROME; EARLY DIAGNOSIS; EXPERT SYSTEM; FACIAL BONE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; KARYOTYPE; MATERNAL AGE; MEDICAL ETHICS; MEDICAL SOCIETY; MOSAICISM; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RELIABILITY; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SKINFOLD THICKNESS; SPONTANEOUS ABORTION; STANDARDIZATION; TECHNIQUE; TREATMENT INDICATION; ULTRASOUND; UNITED KINGDOM;

EID: 0037346591     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(02)00078-7     Document Type: Review

References (27)

1. Chervenak FA, McCullough LB, Chervenak JL. Prenatal informed consent for sonogram: an indication for obstetric ultrasonography. Am J Obstet Gynecol 1989; 161:857-60.
2. Jones KL. Smith's recognizable patterns of human malformation. 5th edition. Philadelphia: WB Saunders; 1997.
3. Benacerraf BR, Barss VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 1985;151:1078-9.
4. Smith-Bindman R, Hosmer W, Feldstein VA, et al. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA 2001;285:1044-55.
5. Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-9.
6. Pandya PP, Santiago C, Snijders RJ, et al. First trimester fetal nuchal translucency. Curr Opin Obstet Gynecol 1995;7:95-102.
7. Pandya PP, Snijders RJM, Johnson SJ, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-62.
8. Snijders RJM, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998;351:343-6.
9. American College of Obstetricians and Gynecologists Committee on Genetics. First-trimester screening for fetal anomalies with nuchal translucency. Committee Opinion Number 223. Washington, DC: American College of Obstetricians and Gynecologists; 1999.
10. O'Callaghan SP, Giles WB, Raymond SP, et al. First trimester ultrasound with nuchal translucency measurement for Down syndrome risk estimation using software developed by the Fetal Medicine Foundation, United Kingdom - the first 2000 examinations in Newcastle, New South Wales, Australia. Aust NZJ Obstet Gynaecol 2000;40:292-5.
11. Theodoropoulos P, Lolis D, Papageorgiou C, et al. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Prenat Diagn 1998;18:133-7.
12. Chasen ST, Skupski DW, McCullough LB, et al. Prenatal informed consent for sonograpm: the time for nuchal translucency has come. J Ultrasound Med 2001;20:1147-51.
13. Gasiorek-Wiens A, Tercanli S, Kozlowski P, et al. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 2001;18:645-8.
14. Zoppi MA, Ibba RM, Floris M, et al. Fetal nuchal translucency screening in 12, 495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001;18:649-51.
15. Brizot ML, Carvalho MHB, Liao AW, et al. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population. Ultrasound Obstet Gynecol 2001; 18:652-5.
16. Wapner RJ. First trimester aneuploid screening: results of the NICHD multicenter study. Am J Obstet Gynecol 2001;185:S70.
17. Hook EB, Mutton DE, Ide R, et al. The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated. Am J Hum Genet 1995;10:356-67.
18. Cuckle H. Integrating antenatal Down's syndrome screening. Curr Opin Obstet Gynecol 2001; 13:175-81.
19. Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001;358:1665-7.
20. Malone FD, Berkowitz RL, Canick JA, et al. First-trimester screening for aneuploidy: research or standard of care. Am J Obstet Gynecol 2000;182:490-6.
21. McCullough LB, Chervenak FA. Ethics in obstetrics and gynecology. New York: Oxford University Press; 1994.
22. Zoppi MA, Ibba RM, Putzolu M, et al. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 2001;97:916-20.
23. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
24. Jenkins TM, Wapner RJ. First trimester prenatal diagnosis: chorionic villus sampling. Semin Perinatol 1999;23:403-13.
25. Alfirevic Z, Gosden CM, Neilson JP. Chorion villus sampling versus amniocentesis for prenatal diagnosis. Cochrane Database Syst Rev 2000;CD000055.
26. Souka AP, Snijders RJ, Novakov A, et al. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:391-400.
27. Kurtz AB, Wapner RJ, Mata J, et al. Twin pregnancies: accuracy of first-trimester abdominal US in predicting chorionicity and amnionicity. Radiology 1992;185:759-62.